The gap between real-world and guidelines in the use of sodium-glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry'.

Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE

Publication: 2014- : Chichester : Wiley
Original Publication: Amsterdam ; New York : Elsevier Science, c1999-

Heart Failure*/drug therapy ; Heart Failure*/physiopathology ; Stroke Volume*/physiology ; Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Practice Guidelines as Topic*; Humans ; Registries ; Sweden/epidemiology

Stolfo D, Lund LH, Benson L, Lindberg F, Ferrannini G, Dahlström U, et al. Real‐world use of sodium‐glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry. Eur J Heart Fail 2023;25:1648–1658. https://doi.org/10.1002/ejhf.2971.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333.
Becher PM, Savarese G, Benson L, Dahlström U, Karlström P, Mol PGM, et al. Eligibility for sotagliflozin in a real‐world heart failure population based on the SOLOIST‐WHF trial enrolment criteria: Data from the Swedish Heart Failure Registry. Eur Heart J Cardiovasc Pharmacother 2023;9:343–352. https://doi.org/10.1093/ehjcvp/pvad012.
Becher PM, Schrage B, Ferrannini G, Benson L, Butler J, Carrero JJ, et al. Use of sodium‐glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: Data from the Swedish Heart Failure Registry. Eur J Heart Fail 2021;23:1012–1022. https://doi.org/10.1002/ejhf.2131.
Lund LH, Carrero JJ, Farahmand B, Henriksson KM, Jonsson Å, Jernberg T, et al. Association between enrolment in a heart failure quality registry and subsequent mortality – a nationwide cohort study. Eur J Heart Fail 2017;19:1107–1116. https://doi.org/10.1002/ejhf.762.

Date Created: 20240208 Date Completed: 20240515 Latest Revision: 20240808

20240809

10.1002/ejhf.3163

38329836